STOCK TITAN

Atrion Stock Price, News & Analysis

ATRI NASDAQ

Company Description

Overview of Atrion Corp (ATRI)

Atrion Corp is a Pennsylvania-based medical device company renowned for its commitment to innovation in clinical solutions and advanced medical technology. With a focus on engineering and manufacturing high-quality medical devices, Atrion serves a diverse clientele, including hospitals, healthcare providers, and diagnostic labs, ensuring reliability and precision in patient care and clinical diagnostics. The company integrates precise engineering practices and regulatory compliance to develop products that meet the rigorous demands of modern medicine.

Core Business and Operational Focus

Central to Atrion Corp's operations is its ability to design and produce a range of medical devices that cater to various clinical needs. The company leverages advanced technology and deep industry expertise to create products that enhance diagnostic accuracy and streamline surgical procedures. Atrion's core business segments emphasize:

  • Medical Device Engineering: Employing cutting-edge design principles and engineering techniques to develop reliable, innovative products.
  • Clinical Solutions: Focusing on devices and systems that improve the accuracy and efficiency of patient diagnosis and treatment.
  • Regulatory Compliance: Ensuring all products meet stringent industry standards, thereby reinforcing trust among healthcare professionals.

Industry Position and Competitive Landscape

Within the competitive landscape of the medical devices industry, Atrion Corp stands out by its unwavering focus on innovation and quality. The company has built a reputation for delivering reliable products that integrate seamlessly with modern healthcare systems. Its approach is characterized by a deep understanding of market needs paired with technical competence in medical instrumentation, positioning Atrion as a credible player in the realm of clinical technologies. Key competitors in this space are also investing in technological advancements, but Atrion differentiates itself through its detailed product development process and commitment to meeting clinical requirements through established engineering practices.

Business Model and Revenue Generation

Atrion Corp operates on a business model that emphasizes product-based revenue streams, including direct sales and contractual service agreements with healthcare providers. The company’s diverse portfolio of medical devices supports a steady revenue mechanism that is closely tied to its commitment to quality and compliance. By consistently updating its product lines and adhering to strict quality standards, Atrion maintains its market relevance and addresses the evolving needs of the healthcare industry.

Market Segments and Strategic Focus

Serving a broad range of market segments within the healthcare industry, Atrion targets:

  • Hospitals and clinics requiring high-precision diagnostic and surgical instruments.
  • Research laboratories that demand accurate medical device solutions.
  • Medical professionals who depend on reliable, timely clinical equipment to improve patient outcomes.

This strategic targeting has allowed Atrion to build a reputable brand that resonates with industry needs and technical expectations, thereby reinforcing its market significance over time.

Technological Innovation and Industry Expertise

Atrion Corp continuously invests in research and development to keep pace with the rapid evolution of medical technology. Its focus on innovation is reflected in the integration of advanced material sciences, digital monitoring systems, and precision engineering in its product designs. By doing so, Atrion not only improves patient care outcomes but also sets a benchmark for quality in the medical devices industry. The company's operations are deeply rooted in technical expertise, regulatory adherence, and rigorous product testing—factors that collectively underscore its reliability and trustworthiness in the sector.

Commitment to Quality and Regulatory Standards

The significance of quality and safety in medical devices cannot be understated. Atrion Corp prioritizes extensive testing and regulatory compliance, ensuring that every product meets or exceeds the stringent standards required in the healthcare field. This commitment is a cornerstone of its operational ethos, bolstering its reputation among clinicians and healthcare institutions alike.

Comprehensive Understanding for Investors and Analysts

For analysts and potential investors evaluating Atrion Corp, the company presents a detailed narrative of technological innovation intertwined with disciplined engineering practices and stringent market compliance. The company’s operational details provide an in-depth insight into the technical, regulatory, and market dynamics that shape its business model. This comprehensive overview highlights Atrion's crucial role in advancing medical device technology and its impact on modern clinical practices.

Stock Performance

$—
0.00%
0.00
Last updated:
-100 %
Performance 1 year
$809.4M
Market Cap
1.8M
Shares outstanding

SEC Filings

No SEC filings available for Atrion.

Financial Highlights

$48,773,000
Revenue (TTM)
$402,000
Net Income (TTM)
$0.23
Diluted EPS (TTM)
$10,981,000
Operating Cash Flow
0.82%
Net Profit Margin
1.09%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Atrion (ATRI)?

The current stock price of Atrion (ATRI) is $457.1 as of August 21, 2024.

What is the market cap of Atrion (ATRI)?

The market cap of Atrion (ATRI) is approximately 809.4M.

What is the revenue (TTM) of Atrion (ATRI) stock?

The trailing twelve months (TTM) revenue of Atrion (ATRI) is $48,773,000.

What is the net income of Atrion (ATRI)?

The trailing twelve months (TTM) net income of Atrion (ATRI) is $402,000.

What is the earnings per share (EPS) of Atrion (ATRI)?

The diluted earnings per share (EPS) of Atrion (ATRI) is $0.23 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Atrion (ATRI)?

The operating cash flow of Atrion (ATRI) is $10,981,000.

What is the profit margin of Atrion (ATRI)?

The net profit margin of Atrion (ATRI) is 0.82%.

What is the operating margin of Atrion (ATRI)?

The operating profit margin of Atrion (ATRI) is 1.09%.

What is the gross margin of Atrion (ATRI)?

The gross profit margin of Atrion (ATRI) is 32.49%.

What is the current ratio of Atrion (ATRI)?

The current ratio of Atrion (ATRI) is 6.80, indicating the company's ability to pay short-term obligations.

What is the gross profit of Atrion (ATRI)?

The gross profit of Atrion (ATRI) is $15,847,000 on a trailing twelve months (TTM) basis.

What is the operating income of Atrion (ATRI)?

The operating income of Atrion (ATRI) is $534,000.

What is the core focus of Atrion Corp?

Atrion Corp specializes in designing and manufacturing innovative medical devices and clinical solutions, emphasizing quality and regulatory compliance.

Where is Atrion Corp headquartered?

The company is based in Plymouth, Pennsylvania, serving a diverse customer base across the healthcare industry.

How does Atrion Corp generate revenue?

Atrion generates revenue primarily through the sale of its advanced medical devices and through service agreements with healthcare providers.

What market segments does Atrion serve?

The company caters to hospitals, clinics, diagnostic labs, and research institutions, addressing various clinical and diagnostic needs.

How does Atrion differentiate itself in the medical device industry?

Atrion differentiates itself through its commitment to innovative engineering, rigorous quality standards, and comprehensive regulatory compliance.

What role does technology play in Atrion Corp's products?

Advanced technology is integral to Atrion's product development, with a focus on integrating new clinical solutions and digital monitoring systems to enhance diagnostic precision.

How is quality maintained in Atrion Corp's operations?

The company maintains high quality through extensive testing, adherence to regulatory standards, and a commitment to engineering excellence in all its product developments.